Issue 8, 2016

Radiolabeled analogs of neurotensin (8–13) containing multiple 1,2,3-triazoles as stable amide bond mimics in the backbone

Abstract

Radiometallated regulatory peptides are a promising class of radiopharmaceuticals for the diagnosis (imaging) and therapy of cancer in nuclear oncology. A limitation of such peptides employed as tumor-specific vectors is represented by their low stability in vivo. Stabilization of the peptides against proteolytic degradation by, e.g., structural modifications, can improve their tumor-targeting properties. We here report an application of our recently introduced peptide stabilization methodology, which involves the substitution of amide bonds in the backbone of peptides by metabolically stable 1,2,3-triazoles. Specifically, we replaced multiple amide bonds by the heterocyclic amide bond mimic in the binding sequence of neurotensin, NT(8–13), and studied in vitro the effect of the modifications on the biological properties of the peptidomimetics obtained (cell internalization, affinity towards the neurotensin receptor subtype 1, blood plasma stability, and log D). In the course of the work, a 177Lu-labeled DOTA-NT(8–13) conjugate bearing two consecutively placed triazoles in its backbone with retained biological function was identified.

Graphical abstract: Radiolabeled analogs of neurotensin (8–13) containing multiple 1,2,3-triazoles as stable amide bond mimics in the backbone

Supplementary files

Article information

Article type
Research Article
Submitted
14 Apr 2016
Accepted
13 Jun 2016
First published
28 Jun 2016

Med. Chem. Commun., 2016,7, 1640-1646

Radiolabeled analogs of neurotensin (8–13) containing multiple 1,2,3-triazoles as stable amide bond mimics in the backbone

A. Mascarin, I. E. Valverde and T. L. Mindt, Med. Chem. Commun., 2016, 7, 1640 DOI: 10.1039/C6MD00208K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements